INCRIntercure Ltd. Ordinary Shares

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · intercure.co

0.8515USDMkt Cap: 50.43M $P/E: —3d ago

InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The c…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.19BUSDP/E 23.7

TAK

Takeda Pharmaceutical Co. Ltd.

$58.06BUSD

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$43.98BUSDP/E 20.4

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

Neurocrine Biosciences, Inc.

$15.51BUSDP/E 22.3

ELAN

Elanco Animal Health Incorporat

$11.98BUSD

RDY

Dr. Reddy's Laboratories Ltd

Hims & Hers Health, Inc.

$7.88BUSD

LNTH

Lantheus Holdings Inc

$6.53BUSDP/E 23.9

AMRX

Amneal Pharmaceuticals, Inc. Class A

Kiniksa Pharmaceuticals, Ltd.

$6.08BUSDP/E 79.8

Key Statistics

Company

Market Cap50.43M $

Enterprise Value—

Revenue (TTM)—

Gross Profit33.18M $

Net Income (TTM)-35.71M $

Revenue/Share—

Last Price0.8515 USD

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees285

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-0.59

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B0.11

EPS (TTM)-0.22

EPS (Forward)-1.48

52W Range

0.85150% of range0.8780

52W High0.8780 USD

52W Low0.8515 USD

Profitability

Gross Margin12.28%

Oper. Margin0.00%

EBITDA Margin-20.48%

Profit Margin-13.22%

ROE-9.01%

ROA-5.17%

Growth

Revenue Growth23.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF16.84M $

CapEx (TTM)3.55M $

FCF Margin—

FCF Yield-74.22%

Net Debt—

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.46

Current Ratio1.48

Quick Ratio0.91

Book Value/Sh7.591 USD

Cash/Share—

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.59.23M

Float38.04M

Insiders39.17%

Institutions1.05%

Short Interest

Short Ratio0.5d

Short % Float0.02%

Short % Out.0.02%

Shares Short10.56K

Short (prev mo.)15.14K

Technical

SMA 500.9655 (-11.8%)

SMA 2000.9839 (-13.5%)

Beta0.57

S&P 52W Chg21.00%

Avg Vol (30d)8.38K

Avg Vol (10d)19.15K

Technical Indicators

RSI (14)37.1

MACD-0.0136

MACD Signal0.0049

MACD Hist.-0.0186

BB Upper1.145 USD

BB Middle1.007 USD

BB Lower0.8686 USD

BB Width27.42%

ATR (14)0.0661 USD

Vol Ratio (20d)0.13x